Bone Biologics Corp (BBLG) is a Healthcare · Biotechnology company listed on NASDAQ. Price $0.51 (+1.22%), Market cap $0.00B, 52-week low–high $0.75 ~ $6.20.
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein in the United States. Its lead product is NELL-1/DBM medical device, an osteopromotive recombinant protein, which provides target specific control over bone regeneration. The company also develops NB1, a NELL-1/DBM fusion device for use in lumbar spinal fusion, as well as spine implants, non-union trauma cases, and osteoporosis applications. It serves spine surgeons and patients with a skeletal bone defect or bone-related condition in their spine. The company has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL
Financial statements, price targets, institutional (13F) holdings and related news for Bone Biologics Corp are updated in real time on BlackAll Trade.
Bone Biologics Corp trades at $0.51 (+1.22%). Real-time quotes and charts are available on BlackAll Trade.
Bone Biologics Corp has a market cap of about $0.00B.
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein in the United States. Its lead product is NELL-1/DBM medical dev